Latest Research Reports

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

Top indications and therapy areas for 2012-2016 clinical trials in Israel

Top indications and therapy areas for 2012-2016 clinical trials in Israel

The global burden of rheumatoid arthritis will increase

The global burden of rheumatoid arthritis will increase

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share

US and UK stand out with higher disease prevalence of two autoimmune diseases

US and UK stand out with higher disease prevalence of two autoimmune diseases

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Cost containment remains strategic driver in outsourcing sector

Total combined peer group operating margin increased by 100 basis points to 12.4% of total sales in 2016, which represented three consecutive years of margin improvement in the outsourcing...

Cost containment remains strategic driver in outsourcing sector

A look at atrial fibrillation’s market size forecast

A look at atrial fibrillation’s market size forecast

Industry-sponsored clinical trials initiated in Q1 2017

Industry-sponsored clinical trials initiated in Q1 2017

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Will competitive US pricing be enough to give Valeant’s Siliq an edge?

Licensing deals in Duchenne Muscular Dystrophy (DMD)

Licensing deals in Duchenne Muscular Dystrophy (DMD)

China shows leading emerging market growth in R&D spend

While the global pharmaceutical markets have typically been dominated by US, Europe and Japan, emerging markets have been steadily increasing their prominence in the global space over the...

China shows leading emerging market growth in R&D spend

Pharma licensing deals 2016/2017 comparison

Pharma licensing deals 2016/2017 comparison

Brazil: 2016 clinical trials activity at lowest point in five years

Brazil: 2016 clinical trials activity at lowest point in five years

Eylea enables Regeneron to dominate the ocular market

Eylea enables Regeneron to dominate the ocular market

Dark clouds: the growing burden of major depressive disorder

Dark clouds: the growing burden of major depressive disorder

Top oncology revenue generators: what will the next five years bring?

Top oncology revenue generators: what will the next five years bring?

A serious threat on the horizon for Imbruvica

A serious threat on the horizon for Imbruvica

India’s 2016 clinical trials activity back to 2008 levels

India’s 2016 clinical trials activity back to 2008 levels

Seven kings of diabetes will remain in power for years to come

Seven kings of diabetes will remain in power for years to come